T cell proliferation and homeostasis: An emerging role for the cell cycle inhibitor geminin

Critical Reviews in Immunology

Volumn 31, Issue 3, 2011, Pages 209-213

  Karamitros, Dimitris ^a   Kotantaki, Panorea ^a   Lygerou, Zoi ^a   Kioussis, Dimitris ^b   Taraviras, Stavros ^a  

^a UNIVERSITY OF PATRAS   (Greece)

^b NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

Cdt1; Chro matin modulation; Geminin; Genomic integrity; Licensing; T cell lineage commitment; T cell proliferation; Transcriptional regulation

Indexed keywords

GEMININ; REPLICATION LICENSING FACTOR CDT1; SMALL INTERFERING RNA; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR;

ARTICLE; AUTOIMMUNE DISEASE; BIOLOGICAL ACTIVITY; CARCINOGENESIS; CELL CYCLE REGULATION; CELL EXPANSION; CELL FATE; CELL LINEAGE; CELL MATURATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; EFFECTOR CELL; GENETIC TRANSCRIPTION; HOMEOSTASIS; HOX GENE; HUMAN; LEUKEMIA; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTOPENIA; NONHUMAN; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; THYMUS;

ANIMALS; CELL CYCLE; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CHROMATIN; CHROMATIN ASSEMBLY AND DISASSEMBLY; EPIGENESIS, GENETIC; HOMEOSTASIS; HUMANS; IMMUNITY; IMMUNOLOGIC MEMORY; LYMPHOCYTE ACTIVATION; MICE; MICE, TRANSGENIC; NUCLEAR PROTEINS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TRANSCRIPTIONAL ACTIVATION;

EID: 79959310498     PISSN: 10408401     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (183)

1. Iwasaki H, Akashi K. Hematopoietic developmental pathways: on cellular basis. Oncogene. 2007 Oct 15;26(47):6687-96.
2. Panopoulos AD, Watowich SS. Granulocyte colony-stimulating factor: molecular mechanisms of action during steady state and 'emergency' hematopoiesis. Cytokine. 2008 Jun;42(3):277-88.
3. Jankovic D, Sher A, Yap G. Th1/Th2 effector choice in parasitic infection: decision making by committee. Curr Opin Immunol. 2001 Aug;13(4):403-9.
4. Aifantis I, Mandal M, Sawai K, Ferrando A, Vilimas T. Regulation of T-cell progenitor survival and cell-cycle entry by the pre-T-cell receptor. Immunol Rev. 2006 Feb;209:159-69.
5. Chi TH, Wan M, Zhao K, Taniuchi I, Chen L, Littman DR, Crabtree GR. Reciprocal regulation of CD4/CD8 expression by SWI/SNF-like BAF complexes. Nature. 2002 Jul 11;418(6894):195-9.
6. Yang Q, Jeremiah Bell J, Bhandoola A. T-cell lineage determination. Immunol Rev. 2010 Nov;238(1):12-22.
7. Carpenter AC, Bosselut R. Decision checkpoints in the thymus. Nat Immunol. 2010 Aug;11(8):666-73.
8. Kioussis D, Ellmeier W. Chromatin and CD4, CD8A and CD8B gene expression during thymic differentiation. Nat Rev Immunol. 2002 Dec;2(12):909-19.
9. Karamitros D, Kotantaki P, Lygerou Z, Veiga-Fernandes H, Pachnis V, Kioussis D, Taraviras S. Differential gemi-nin requirement for proliferation of thymocytes and mature T cells. J Immunol. 2010 Mar 1;184(5):2432-41.
10. Harman BC, Jenkinson EJ, Anderson G. Microenviron-mental regulation of Notch signalling in T cell development. Semin Immunol. 2003 Apr;15(2):91-7.
11. Sambandam A, Maillard I, Zediak VP, Xu L, Gerstein RM, Aster JC, Pear WS, Bhandoola A. Notch signaling controls the generation and differentiation of early T lineage progenitors. Nat Immunol. 2005 Jul;6(7):663-70.
12. Penit C, Lucas B, Vasseur F. Cell expansion and growth arrest phases during the transition from precursor (CD4-8-) to immature (CD4+8+) thymocytes in normal and genetically modifed mice. J Immunol. 1995 May 15;154(10):5103-13.
13. Ellmeier W, Sawada S, Littman DR. The regulation of CD4 and CD8 coreceptor gene expression during T cell development. Annu Rev Immunol. 1999;17:523-54.
14. Hoffman ES, Passoni L, Crompton T, Leu TM, Schatz DG, Koff A, Owen MJ, Hayday AC. Productive T-cell receptor beta-chain gene rearrangement: coincident regulation of cell cycle and clonality during development in vivo. Genes Dev. 1996 Apr 15;10(8):948-62.
15. Saito T, Watanabe N. Positive and negative thymocyte selection. Crit Rev Immunol. 1998;18(4):359-70.
16. Tourigny MR, Mazel S, Burtrum DB, Petrie HT. T cell receptor (TCR)-beta gene recombination: dissociation from cell cycle regulation and developmental progression during T cell ontogeny. J Exp Med. 1997 May 5;185(9):1549-56.
17. Sicinski P, Donaher JL, Parker SB, Li T, Fazeli A, Gardner H, Haslam SZ, Bronson RT, Elledge SJ, Weinberg RA. Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell. 1995 Aug 25;82(4):621-30.
18. Sicinski P, Donaher JL, Geng Y, Parker SB, Gardner H, Park MY, Robker RL, Richards JS, McGinnis LK, Big-gers JD, Eppig JJ, Bronson RT, Elledge SJ, Weinberg RA. Cyclin D2 is an FSH-responsive gene involved in gonad-al cell proliferation and oncogenesis. Nature. 1996 Dec 5;384(6608):470-4.
19. Sicinska E, Aifantis I, Le Cam L, Swat W, Borowski C, Yu Q, Ferrando AA, Levin SD, Geng Y, von Boehmer H, Sicinski P. Requirement for cyclin D3 in lymphocyte development and T cell leukemias. Cancer Cell. 2003 Dec;4(6):451-61.
20. Karsunky H, Geisen C, Schmidt T, Haas K, Zevnik B, Gau E, Moroy T. Oncogenic potential of cyclin E in T-cell lymphomagenesis in transgenic mice: evidence for cooperation between cyclin E and Ras but not Myc. Oncogene. 1999 Dec 16;18(54):7816-24.
21. Murphy M, Stinnakre MG, Senamaud-Beaufort C, Winston NJ, Sweeney C, Kubelka M, Carrington M, Brechot C, Sobczak-Thepot J. Delayed early embryonic lethality following disruption of the murine cyclin A2 gene. Nat Genet. 1997 Jan;15(1):83-6.
22. Brandeis M, Rosewell I, Carrington M, Crompton T, Jacobs MA, Kirk J, Gannon J, Hunt T. Cyclin B2-null mice develop normally and are fertile whereas cyclin B1-null mice die in utero. Proc Natl Acad Sci U S A. 1998 Apr 14;95(8):4344-9.
23. Kalaszczynska I, Geng Y, Iino T, Mizuno S, Choi Y, Kon-dratiuk I, Silver DP, Wolgemuth DJ, Akashi K, Sicinski P. Cyclin A is redundant in fbroblasts but essential in hematopoietic and embryonic stem cells. Cell. 2009 Jul 23;138(2):352-65.
24. Hu MG, Deshpande A, Enos M, Mao D, Hinds EA, Hu GF, Chang R, Guo Z, Dose M, Mao C, Tsichlis PN, Gounari F, Hinds PW. A requirement for cyclin-dependent kinase 6 in thymocyte development and tumorigenesis. Cancer Res. 2009 Feb 1;69(3):810-8.
25. Rane SG, Dubus P, Mettus RV, Galbreath EJ, Boden G, Reddy EP, Barbacid M. Loss of Cdk4 expression causes insulin-defcient diabetes and Cdk4 activation results in beta-islet cell hyperplasia. Nat Genet. 1999 May;22(1):44-52.
26. Berthet C, Aleem E, Coppola V, Tessarollo L, Kaldis P. Cdk2 knockout mice are viable. Curr Biol. 2003 Oct 14;13(20):1775-85.
27. Kiyokawa H, Kineman RD, Manova-Todorova KO, Soares VC, Hoffman ES, Ono M, Khanam D, Hayday AC, Fro-hman LA, Koff A. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1). Cell. 1996 May 31;85(5):721-32.
28. Tsukiyama T, Ishida N, Shirane M, Minamishima YA, Hatakeyama S, Kitagawa M, Nakayama K, Nakayama K. Down-regulation of p27Kip1 expression is required for development and function of T cells. J Immunol. 2001 Jan 1;166(1):304-12.
29. Martin-Caballero J, Flores JM, Garcia-Palencia P, Collado M, Serrano M. Different cooperating effect of p21 or p27 defciency in combination with INK4a/ARF deletion in mice. Oncogene. 2004 Oct 28;23(50):8231-7.
30. Tomita K, Hattori M, Nakamura E, Nakanishi S, Minato N, Kageyama R. The bHLH gene Hes1 is essential for expansion of early T cell precursors. Genes Dev. 1999 May 1;13(9):1203-10.
31. Radtke F, Wilson A, Stark G, Bauer M, van Meerwijk J, MacDonald HR, Aguet M. Defcient T cell fate specifca-tion in mice with an induced inactivation of Notch1. Immunity. 1999 May;10(5):547-58.
32. Pui JC, Allman D, Xu L, DeRocco S, Karnell FG, Bak-kour S, Lee JY, Kadesch T, Hardy RR, Aster JC, Pear WS. Notch1 expression in early lymphopoiesis influences B versus T lineage determination. Immunity. 1999 Sep;11(3):299-308.
33. Spain LM, Guerriero A, Kunjibettu S, Scott EW. T cell development in PU.1-defcient mice. J Immunol. 1999 Sep 1;163(5):2681-7.
34. Anderson MK, Hernandez-Hoyos G, Diamond RA, Rothen-berg E V. Precise developmental regulation of Ets family transcription factors during specifcation and commitment to the T cell lineage. Development. 1999 Jun;126(14):3131-48.
35. Ting CN, Olson MC, Barton KP, Leiden JM. Transcription factor GATA-3 is required for development of the T-cell lineage. Nature. 1996 Dec 5;384(6608):474-8.
36. Collins A, Littman DR, Taniuchi I. RUNX proteins in transcription factor networks that regulate T-cell lineage choice. Nat Rev Immunol. 2009 Feb;9(2):106-15.
37. Pai SY, Truitt ML, Ting CN, Leiden JM, Glimcher LH, Ho IC. Critical roles for transcription factor GATA-3 in thy-mocyte development. Immunity. 2003 Dec;19(6):863-75.
38. Taniuchi I, Osato M, Egawa T, Sunshine MJ, Bae SC, Ko-mori T, Ito Y, Littman DR. Differential requirements for Runx proteins in CD4 repression and epigenetic silencing during T lymphocyte development. Cell. 2002 Nov 27;111(5):621-33.
39. Wang JH, Nichogiannopoulou A, Wu L, Sun L, Sharpe AH, Bigby M, Georgopoulos K. Selective defects in the development of the fetal and adult lymphoid system in mice with an Ikaros null mutation. Immunity. 1996 Dec;5(6):537-49.
40. Harker N, Naito T, Cortes M, Hostert A, Hirschberg S, Tolaini M, Roderick K, Georgopoulos K, Kioussis D. The CD8alpha gene locus is regulated by the Ikaros family of proteins. Mol Cell. 2002 Dec;10(6):1403-15.
41. Taghon T, Thys K, De Smedt M, Weerkamp F, Staal FJ, Plum J, Leclercq G. Homeobox gene expression profle in human hematopoietic multipotent stem cells and T-cell progenitors: implications for human T-cell development. Leukemia. 2003 Jun;17(6):1157-63.
42. Izon DJ, Rozenfeld S, Fong ST, Komuves L, Largman C, Lawrence HJ. Loss of function of the homeobox gene Hoxa-9 perturbs early T-cell development and induces apoptosis in primitive thymocytes. Blood. 1998 Jul 15;92(2):383-93.
43. Sauvageau G, Thorsteinsdottir U, Hough MR, Hugo P, Lawrence HJ, Largman C, Humphries RK. Overexpres-sion of HOXB3 in hematopoietic cells causes defective lymphoid development and progressive myeloprolifera-tion. Immunity. 1997 Jan;6(1):13-22.
44. Chi TH, Wan M, Lee PP, Akashi K, Metzger D, Cham-bon P, Wilson CB, Crabtree GR. Sequential roles of Brg, the ATPase subunit of BAF chromatin remodeling complexes, in thymocyte development. Immunity. 2003 Aug;19(2):169-82.
45. Gebuhr TC, Kovalev GI, Bultman S, Godfrey V, Su L, Magnuson T. The role of Brg1, a catalytic subunit of mammalian chromatin-remodeling complexes, in T cell development. J Exp Med. 2003 Dec 15;198(12):1937-49.
46. Simon JA, Kingston RE. Mechanisms of polycomb gene silencing: knowns and unknowns. Nat Rev Mol Cell Biol. 2009 Oct;10(10):697-708.
47. van der Lugt NM, Domen J, Linders K, van Roon M, Robanus-Maandag E, te Riele H, van der Valk M, De-schamps J, Sofroniew M, van Lohuizen M, et al. Posterior transformation, neurological abnormalities, and severe hematopoietic defects in mice with a targeted deletion of the bmi-1 proto-oncogene. Genes Dev. 1994 Apr 1;8(7):757-69.
48. Miyazaki M, Miyazaki K, Itoi M, Katoh Y, Guo Y, Kanno R, Katoh-Fukui Y, Honda H, Amagai T, van Lohuizen M, Kawamoto H, Kanno M. Thymocyte proliferation induced by pre-T cell receptor signaling is maintained through polycomb gene product Bmi-1-mediated Cdkn2a repression. Immunity. 2008 Feb;28(2):231-45.
49. Richie ER, Schumacher A, Angel JM, Holloway M, Rin-chik EM, Magnuson T. The Polycomb-group gene eed regulates thymocyte differentiation and suppresses the development of carcinogen-induced T-cell lymphomas. On-cogene. 2002 Jan 10;21(2):299-306.
50. Rocha B, Dautigny N, Pereira P. Peripheral T lymphocytes: expansion potential and homeostatic regulation of pool sizes and CD4/CD8 ratios in vivo. Eur J Immunol. 1989 May;19(5):905-11.
51. Bell EB, Sparshott SM, Drayson MT, Ford WL. The stable and permanent expansion of functional T lymphocytes in athymic nude rats after a single injection of mature T cells. J Immunol. 1987 Sep 1;139(5):1379-84.
52. Effros RB. Long-term immunological memory against viruses. Mech Ageing Dev. 2000 Dec 20;121(1-3):161-71.
53. Miller RA. The aging immune system: primer and prospectus. Science. 1996 Jul 5;273(5271):70-4.
54. Olsen NJ, Kovacs WJ. Effects of androgens on T and B lymphocyte development. Immunol Res. 2001;23(2- 3):281-8.
55. Mackall CL, Bare CV, Granger LA, Sharrow SO, Titus JA, Gress RE. Thymic-independent T cell regeneration occurs via antigen-driven expansion of peripheral T cells resulting in a repertoire that is limited in diversity and prone to skewing. J Immunol. 1996 Jun 15;156(12):4609-16.
56. Kaech SM, Wherry EJ, Ahmed R. Effector and memory T-cell differentiation: implications for vaccine development. Nat Rev Immunol. 2002 Apr;2(4):251-62.
57. Tough DF, Sprent J. Turnover of naive- and memory-phe-notype T cells. J Exp Med. 1994 Apr 1;179(4):1127-35.
58. Kieper WC, Jameson SC. Homeostatic expansion and phe-notypic conversion of naive T cells in response to self pep-tide/MHC ligands. Proc Natl Acad Sci U S A. 1999 Nov 9;96(23):13306-11.
59. Rocha B, von Boehmer H. Peripheral selection of the T cell repertoire. Science. 1991 Mar 8;251(4998):1225-8.
60. Tanchot C, Lemonnier FA, Perarnau B, Freitas AA, Rocha B. Differential requirements for survival and proliferation of CD8 naive or memory T cells. Science. 1997 Jun 27;276(5321):2057-62.
61. Kopf M, Ruedl C, Schmitz N, Gallimore A, Lefrang K, Ecabert B, Odermatt B, Bachmann MF. OX40-defcient mice are defective in Th cell proliferation but are competent in generating B cell and CTL Responses after virus infection. Immunity. 1999 Dec;11(6):699-708.
62. Shahinian A, Pfeffer K, Lee KP, Kundig TM, Kishihara K, Wakeham A, Kawai K, Ohashi PS, Thompson CB, Mak TW. Differential T cell costimulatory requirements in CD28-defcient mice. Science. 1993 Jul 30;261(5121):609-12.
63. Whitmire JK, Flavell RA, Grewal IS, Larsen CP, Pearson TC, Ahmed R. CD40-CD40 ligand costimulation is required for generating antiviral CD4 T cell responses but is dispensable for CD8 T cell responses. J Immunol. 1999 Sep 15;163(6):3194-201.
64. Ma A, Koka R, Burkett P. Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis. Annu Rev Immunol. 2006;24:657-79.
65. Foulds KE, Zenewicz LA, Shedlock DJ, Jiang J, Troy AE, Shen H. Cutting edge: CD4 and CD8 T cells are intrinsically different in their proliferative responses. J Immunol. 2002 Feb 15;168(4):1528-32.
66. Seder RA, Gazzinelli R, Sher A, Paul WE. Interleukin 12 acts directly on CD4+ T cells to enhance priming for in-terferon gamma production and diminishes interleukin 4 inhibition of such priming. Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):10188-92.
67. Magram J, Connaughton SE, Warrier RR, Carvajal DM, Wu CY, Ferrante J, Stewart C, Sarmiento U, Faherty DA, Gately MK. IL-12-defcient mice are defective in IFN gamma production and type 1 cytokine responses. Immunity. 1996 May;4(5):471-81.
68. Thierfelder WE, van Deursen JM, Yamamoto K, Tripp RA, Sarawar SR, Carson RT, Sangster MY, Vignali DA, Do-herty PC, Grosveld GC, Ihle JN. Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature. 1996 Jul 11;382(6587):171-4.
69. Lohoff M, Ferrick D, Mittrucker HW, Duncan GS, Bischof S, Rollinghoff M, Mak TW. Interferon regulatory factor-1 is required for a T helper 1 immune response in vivo. Immunity. 1997 Jun;6(6):681-9.
70. Coccia EM, Passini N, Battistini A, Pini C, Sinigaglia F, Rogge L. Interleukin-12 induces expression of interfer-on regulatory factor-1 via signal transducer and activator of transcription-4 in human T helper type 1 cells. J Biol Chem. 1999 Mar 5;274(10):6698-703.
71. Kaplan MH, Sun YL, Hoey T, Grusby MJ. Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-defcient mice. Nature. 1996 Jul 11;382(6587):174-7.
72. Szabo SJ, Kim ST, Costa GL, Zhang X, Fathman CG, Glimcher LH. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell. 2000 Mar 17;100(6):655-69.
73. Aronica MA, Mora AL, Mitchell DB, Finn PW, Johnson JE, Sheller JR, Boothby MR. Preferential role for NF-kap-pa B/Rel signaling in the type 1 but not type 2 T cell-dependent immune response in vivo. J Immunol. 1999 Nov 1;163(9):5116-24.
74. Yamashita M, Kuwahara M, Suzuki A, Hirahara K, Shin-naksu R, Hosokawa H, Hasegawa A, Motohashi S, Iwama A, Nakayama T. Bmi1 regulates memory CD4 T cell survival via repression of the Noxa gene. J Exp Med. 2008 May 12;205(5):1109-20.
75. Le Gros G, Ben-Sasson SZ, Seder R, Finkelman FD, Paul WE. Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4-producing cells. J Exp Med. 1990 Sep 1;172(3):921-9.
76. Shimoda K, van Deursen J, Sangster MY, Sarawar SR, Carson RT, Tripp RA, Chu C, Quelle FW, Nosaka T, Vi-gnali DA, Doherty PC, Grosveld G, Paul WE, Ihle JN. Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature. 1996 Apr 18;380(6575):630-3.
77. Zheng W, Flavell RA. The transcription factor GATA-3 is necessary and suffcient for Th2 cytokine gene expression in CD4 T cells. Cell. 1997 May 16;89(4):587-96.
78. Quirion MR, Gregory GD, Umetsu SE, Winandy S, Brown MA. Cutting edge: Ikaros is a regulator of Th2 cell differentiation. J Immunol. 2009 Jan 15;182(2):741-5.
79. Hosokawa H, Kimura MY, Shinnakasu R, Suzuki A, Miki T, Koseki H, van Lohuizen M, Yamashita M, Nakayama T. Regulation of Th2 cell development by Polycomb group gene bmi-1 through the stabilization of GATA3. J Immunol. 2006 Dec 1;177(11):7656-64.
80. Ansel KM, Djuretic I, Tanasa B, Rao A. Regulation of Th2 differentiation and Il4 locus accessibility. Annu Rev Immunol. 2006;24:607-56.
81. Hatton RD, Harrington LE, Luther RJ, Wakefeld T, Janowski KM, Oliver JR, Lallone RL, Murphy KM, Weaver CT. A distal conserved sequence element controls Ifng gene expression by T cells and NK cells. Immunity. 2006 Nov;25(5):717-29.
82. Swain SL. Generation and in vivo persistence of polarized Th1 and Th2 memory cells. Immunity. 1994 Oct;1(7):543-52.
83. Seddon B, Tomlinson P, Zamoyska R. Interleukin 7 and T cell receptor signals regulate homeostasis of CD4 memory cells. Nat Immunol. 2003 Jul;4(7):680-6.
84. Kassiotis G, Garcia S, Simpson E, Stockinger B. Impairment of immunological memory in the absence of MHC despite survival of memory T cells. Nat Immunol. 2002 Mar;3(3):244-50.
85. Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol. 2003 Apr;4(4):330-6.
86. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003 Feb 14;299(5609):1057-61.
87. O'Garra A, Vieira P. Regulatory T cells and mechanisms of immune system control. Nat Med. 2004 Aug;10(8):801-5.
88. Bettelli E, Dastrange M, Oukka M. Foxp3 interacts with nuclear factor of activated T cells and NF-kappa B to repress cytokine gene expression and effector functions of T helper cells. Proc Natl Acad Sci U S A. 2005 Apr 5;102(14):5138-43.
89. Kasprowicz DJ, Smallwood PS, Tyznik AJ, Ziegler SF. Scurfn (FoxP3) controls T-dependent immune responses in vivo through regulation of CD4+ T cell effector function. J Immunol. 2003 Aug 1;171(3):1216-23.
90. Jani A, Chi T, Wan Y Y. Chromatin remodeling complex in Treg function. Int Immunopharmacol. 2009 May;9(5):521-3.
91. McGarry TJ, Kirschner MW. Geminin, an inhibitor of DNA replication, is degraded during mitosis. Cell. 1998 Jun 12;93(6):1043-53.
92. Blow JJ, Dutta A. Preventing re-replication of chromosomal DNA. Nat Rev Mol Cell Biol. 2005 Jun;6(6):476-86.
93. Kroll KL, Salic AN, Evans LM, Kirschner MW. Geminin, a neuralizing molecule that demarcates the future neural plate at the onset of gastrulation. Development. 1998 Aug;125(16):3247-58.
94. Nishitani H, Lygerou Z. Control of DNA replication licensing in a cell cycle. Genes Cells. 2002 Jun;7(6):523-34.
95. DePamphilis ML, Blow JJ, Ghosh S, Saha T, Noguchi K, Vassilev A. Regulating the licensing of DNA replication origins in metazoa. Curr Opin Cell Biol. 2006 Jun;18(3):231-9.
96. Bell SP, Kobayashi R, Stillman B. Yeast origin recognition complex functions in transcription silencing and DNA replication. Science. 1993 Dec 17;262(5141):1844-9.
97. Piatti S, Lengauer C, Nasmyth K. Cdc6 is an unstable protein whose de novo synthesis in G1 is important for the onset of S phase and for preventing a 'reductional' anaphase in the budding yeast Saccharomyces cerevisiae. Embo J. 1995 Aug 1;14(15):3788-99.
98. Nishitani H, Lygerou Z, Nishimoto T, Nurse P. The Cdt1 protein is required to license DNA for replication in fssion yeast. Nature. 2000 Apr 6;404(6778):625-8.
99. Rowles A, Blow JJ. Chromatin proteins involved in the initiation of DNA replication. Curr Opin Genet Dev. 1997 Apr;7(2):152-7.
100. Maiorano D, Rul W, Mechali M. Cell cycle regulation of the licensing activity of Cdt1 in Xenopus laevis. Exp Cell Res. 2004 Apr 15;295(1):138-49.
101. Tada S, Li A, Maiorano D, Mechali M, Blow JJ. Repression of origin assembly in metaphase depends on inhibition of RLF-B/Cdt1 by geminin. Nat Cell Biol. 2001 Feb;3(2):107-13.
102. Dutta A, Bell SP. Initiation of DNA replication in eukary-otic cells. Annu Rev Cell Dev Biol. 1997;13:293-332.
103. Diffey JF. Regulation of early events in chromosome replication. Curr Biol. 2004 Sep 21;14(18):R778-86.
104. Hook SS, Lin JJ, Dutta A. Mechanisms to control rerep-lication and implications for cancer. Curr Opin Cell Biol. 2007 Dec;19(6):663-71.
105. Hu J, Xiong Y. An evolutionarily conserved function of proliferating cell nuclear antigen for Cdt1 degradation by the Cul4-Ddb1 ubiquitin ligase in response to DNA damage. J Biol Chem. 2006 Feb 17;281(7):3753-6.
106. Senga T, Sivaprasad U, Zhu W, Park JH, Arias EE, Walter JC, Dutta A. PCNA is a cofactor for Cdt1 degradation by CUL4/DDB1-mediated N-terminal ubiquitination. J Biol Chem. 2006 Mar 10;281(10):6246-52.
107. Nishitani H, Sugimoto N, Roukos V, Nakanishi Y, Saijo M, Obuse C, Tsurimoto T, Nakayama KI, Nakayama K, Fujita M, Lygerou Z, Nishimoto T. Two E3 ubiquitin li-gases, SCF-Skp2 and DDB1-Cul4, target human Cdt1 for proteolysis. Embo J. 2006 Mar 8;25(5):1126-36.
108. Wohlschlegel JA, Dwyer BT, Dhar SK, Cvetic C, Walter JC, Dutta A. Inhibition of eukaryotic DNA replication by geminin binding to Cdt1. Science. 2000 Dec 22;290(5500):2309-12.
109. Li A, Blow JJ. Non-proteolytic inactivation of geminin requires CDK-dependent ubiquitination. Nat Cell Biol. 2004 Mar;6(3):260-7.
110. Boos A, Lee A, Thompson DM, Kroll KL. Subcellular translocation signals regulate Geminin activity during embryonic development. Biol Cell. 2006 Jun;98(6):363-75.
111. Luo L, Uerlings Y, Happel N, Asli NS, Knoetgen H, Kessel M. Regulation of geminin functions by cell cycle-dependent nuclear-cytoplasmic shuttling. Mol Cell Biol. 2007 Jul;27(13):4737-44.
112. Nishitani H, Lygerou Z, Nishimoto T. Proteolysis of DNA replication licensing factor Cdt1 in S-phase is performed independently of geminin through its N-terminal region. J Biol Chem. 2004 Jul 16;279(29):30807-16.
113. Li A, Blow JJ. Cdt1 downregulation by proteolysis and geminin inhibition prevents DNA re-replication in Xeno-pus. Embo J. 2005 Jan 26;24(2):395-404.
114. Vaziri C, Saxena S, Jeon Y, Lee C, Murata K, Machida Y, Wagle N, Hwang DS, Dutta A. A p53-dependent checkpoint pathway prevents rereplication. Mol Cell. 2003 Apr;11(4):997-1008.
115. Liontos M, Koutsami M, Sideridou M, Evangelou K, Kletsas D, Levy B, Kotsinas A, Nahum O, Zoumpourlis V, Kouloukoussa M, Lygerou Z, Taraviras S, Kittas C, Bartkova J, Papavassiliou AG, Bartek J, Halazonetis TD, Gorgoulis VG. Deregulated overexpression of hCdt1 and hCdc6 promotes malignant behavior. Cancer Res. 2007 Nov 15;67(22):10899-909.
116. Tatsumi Y, Sugimoto N, Yugawa T, Narisawa-Saito M, Kiyono T, Fujita M. Deregulation of Cdt1 induces chromosomal damage without rereplication and leads to chromosomal instability. J Cell Sci. 2006 Aug 1;119(Pt 15):3128-40.
117. Liu E, Lee AY, Chiba T, Olson E, Sun P, Wu X. The ATR-mediated S phase checkpoint prevents rereplication in mammalian cells when licensing control is disrupted. J Cell Biol. 2007 Nov 19;179(4):643-57.
118. Petropoulou C, Kotantaki P, Karamitros D, Taraviras S. Cdt1 and Geminin in cancer: markers or triggers of malignant transformation? Front Biosci. 2008;13:4485-94.
119. Arentson E, Faloon P, Seo J, Moon E, Studts JM, Fremont DH, Choi K. Oncogenic potential of the DNA replication licensing protein CDT1. Oncogene. 2002 Feb 14;21(8):1150-8.
120. Seo J, Chung YS, Sharma GG, Moon E, Burack WR, Pan-dita TK, Choi K. Cdt1 transgenic mice develop lympho-blastic lymphoma in the absence of p53. Oncogene. 2005 Dec 8;24(55):8176-86.
121. Melixetian M, Ballabeni A, Masiero L, Gasparini P, Zam-poni R, Bartek J, Lukas J, Helin K. Loss of Geminin induces rereplication in the presence of functional p53. J Cell Biol. 2004 May 24;165(4):473-82.
122. Zhu W, Chen Y, Dutta A. Rereplication by depletion of geminin is seen regardless of p53 status and activates a G2/M checkpoint. Mol Cell Biol. 2004 Aug;24(16):7140- 50.
123. McGarry TJ. Geminin defciency causes a Chk1-de-pendent G2 arrest in Xenopus. Mol Biol Cell. 2002 Oct;13(10):3662-71.
124. Mihaylov IS, Kondo T, Jones L, Ryzhikov S, Tanaka J, Zheng J, Higa LA, Minamino N, Cooley L, Zhang H. Control of DNA replication and chromosome ploidy by geminin and cyclin A. Mol Cell Biol. 2002 Mar;22(6):1868-80.
125. Ding Q, MacAlpine DM. Preferential re-replication of Drosophila heterochromatin in the absence of geminin. PLoS Genet. 2010;6(9):pii:e1001112.
126. Kulartz M, Knippers R. The replicative regulator protein geminin on chromatin in the HeLa cell cycle. J Biol Chem. 2004 Oct 1;279(40):41686-94.
127. Zhu W, Depamphilis ML. Selective killing of cancer cells by suppression of geminin activity. Cancer Res. 2009 Jun 1;69(11):4870-7.
128. Quinn LM, Herr A, McGarry TJ, Richardson H. The Dros-ophila Geminin homolog: roles for Geminin in limiting DNA replication, in anaphase and in neurogenesis. Genes Dev. 2001 Oct 15;15(20):2741-54.
129. Del Bene F, Tessmar-Raible K, Wittbrodt J. Direct interaction of geminin and Six3 in eye development. Nature. 2004 Feb 19;427(6976):745-9.
130. Luo L, Yang X, Takihara Y, Knoetgen H, Kessel M. The cell-cycle regulator geminin inhibits Hox function through direct and polycomb-mediated interactions. Nature. 2004 Feb 19;427(6976):749-53.
131. Pitulescu ME, Teichmann M, Luo L, Kessel M. TIPT2 and geminin interact with basal transcription factors to synergize in transcriptional regulation. BMC Biochem. 2009;10:16.
132. Kim MY, Jeong BC, Lee JH, Kee HJ, Kook H, Kim NS, Kim YH, Kim JK, Ahn KY, Kim KK. A repressor complex, AP4 transcription factor and geminin, negatively regulates expression of target genes in nonneuronal cells. Proc Natl Acad Sci U S A. 2006 Aug 29;103(35):13074-9.
133. Seo S, Herr A, Lim JW, Richardson GA, Richardson H, Kroll KL. Geminin regulates neuronal differentiation by antagonizing Brg1 activity. Genes Dev. 2005 Jul 15;19(14):1723-34.
134. Papanayotou C, Mey A, Birot AM, Saka Y, Boast S, Smith JC, Samarut J, Stern CD. A mechanism regulating the onset of Sox2 expression in the embryonic neural plate. PLoS Biol. 2008 Jan;6(1):e2.
135. Gonzalez MA, Tachibana KE, Adams DJ, van der Wey-den L, Hemberger M, Coleman N, Bradley A, Laskey RA. Geminin is essential to prevent endoreduplication and to form pluripotent cells during mammalian development. Genes Dev. 2006 Jul 15;20(14):1880-4.
136. Ohno Y, Yasunaga S, Ohtsubo M, Mori S, Tsumura M, Okada S, Ohta T, Ohtani K, Kobayashi M, Takihara Y. Hoxb4 transduction down-regulates Geminin protein, providing hematopoietic stem and progenitor cells with proliferation potential. Proc Natl Acad Sci U S A. 2010 Dec 14;107(50):21529-34.
137. Ohtsubo M, Yasunaga S, Ohno Y, Tsumura M, Okada S, Ishikawa N, Shirao K, Kikuchi A, Nishitani H, Kobayashi M, Takihara Y. Polycomb-group complex 1 acts as an E3 ubiquitin ligase for Geminin to sustain hematopoiet-ic stem cell activity. Proc Natl Acad Sci U S A. 2008 Jul 29;105(30):10396-401.
138. Shinnick KM, Eklund EA, McGarry TJ. Geminin deletion from hematopoietic cells causes anemia and thrombocyto-sis in mice. J Clin Invest. 2010 Dec 1;120(12):4303-15.
139. Hara K, Nakayama KI, Nakayama K. Geminin is essential for the development of preimplantation mouse embryos. Genes Cells. 2006 Nov;11(11):1281-93.
140. Karamitros D, Kotantaki P, Lygerou Z, Veiga-Fernandes H, Pachnis V, Kioussis D, Taraviras S. Life without gemi-nin. Cell Cycle. 2010 Aug 15;9(16):3181-5.
141. Xouri G, Lygerou Z, Nishitani H, Pachnis V, Nurse P, Tara-viras S. Cdt1 and geminin are down-regulated upon cell cycle exit and are over-expressed in cancer-derived cell lines. Eur J Biochem. 2004 Aug;271(16):3368-78.
142. de Boer J, Williams A, Skavdis G, Harker N, Coles M, Tolaini M, Norton T, Williams K, Roderick K, Potocnik AJ, Kioussis D. Transgenic mice with hematopoietic and lymphoid specifc expression of Cre. Eur J Immunol. 2003 Feb;33(2):314-25.
143. Kroll KL. Geminin in embryonic development: coordinating transcription and the cell cycle during differentiation. Front Biosci. 2007;12:1395-409.
144. Geng Y, Yu Q, Sicinska E, Das M, Schneider JE, Bhat-tacharya S, Rideout WM, Bronson RT, Gardner H, Sicin-ski P. Cyclin E ablation in the mouse. Cell. 2003 Aug 22;114(4):431-43.
145. Fantl V, Stamp G, Andrews A, Rosewell I, Dickson C. Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. Genes Dev. 1995 Oct 1;9(19):2364-72.
146. Lam EW, Glassford J, Banerji L, Thomas NS, Sicin-ski P, Klaus GG. Cyclin D3 compensates for loss of cyclin D2 in mouse B-lymphocytes activated via the antigen receptor and CD40. J Biol Chem. 2000 Feb 4;275(5):3479-84.
147. Chen B, Pollard JW. Cyclin D2 compensates for the loss of cyclin D1 in estrogen-induced mouse uterine epithelial cell proliferation. Mol Endocrinol. 2003 Jul;17(7):1368-81.
148. Prlic M, Jameson SC. Homeostatic expansion versus antigen-driven proliferation: common ends by different means? Microbes Infect. 2002 Apr;4(5):531-7.
149. Dummer W, Ernst B, LeRoy E, Lee D, Surh C. Autologous regulation of naive T cell homeostasis within the T cell compartment. J Immunol. 2001 Feb 15;166(4):2460-8.
150. Surh CD, Sprent J. Homeostasis of naive and memory T cells. Immunity. 2008 Dec 19;29(6):848-62.
151. Haluszczak C, Akue AD, Hamilton SE, Johnson LD, Pu-janauski L, Teodorovic L, Jameson SC, Kedl RM. The antigen-specific CD8+ T cell repertoire in unimmunized mice includes memory phenotype cells bearing markers of homeostatic expansion. J Exp Med. 2009 Feb 16;206(2):435-48.
152. Campisi J, d'Adda di Fagagna F. Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol. 2007 Sep;8(9):729-40.
153. Effros RB, Dagarag M, Spaulding C, Man J. The role of CD8+ T-cell replicative senescence in human aging. Immunol Rev. 2005 Jun;205:147-57.
154. Sugimoto N, Tatsumi Y, Tsurumi T, Matsukage A, Ki-yono T, Nishitani H, Fujita M. Cdt1 phosphorylation by cyclin A-dependent kinases negatively regulates its function without affecting geminin binding. J Biol Chem. 2004 May 7;279(19):19691-7.
155. Liu E, Li X, Yan F, Zhao Q, Wu X. Cyclin-dependent ki-nases phosphorylate human Cdt1 and induce its degradation. J Biol Chem. 2004 Apr 23;279(17):17283-8.
156. Takeda DY, Parvin JD, Dutta A. Degradation of Cdt1 during S phase is Skp2-independent and is required for ef-fcient progression of mammalian cells through S phase. J Biol Chem. 2005 Jun 17;280(24):23416-23.
157. Li X, Zhao Q, Liao R, Sun P, Wu X. The SCF(Skp2) ubiq-uitin ligase complex interacts with the human replication licensing factor Cdt1 and regulates Cdt1 degradation. J Biol Chem. 2003 Aug 15;278(33):30854-8.
158. Hu J, McCall CM, Ohta T, Xiong Y. Targeted ubiquitination of CDT1 by the DDB1-CUL4A-ROC1 ligase in response to DNA damage. Nat Cell Biol. 2004 Oct;6(10):1003-9.
159. Zhong W, Feng H, Santiago FE, Kipreos ET. CUL-4 ubiquitin ligase maintains genome stability by restraining DNA-repli-cation licensing. Nature. 2003 Jun 19;423(6942):885-9.
160. Machida YJ, Dutta A. The APC/C inhibitor, Emi1, is essential for prevention of rereplication. Genes Dev. 2007 Jan 15;21(2):184-94.
161. Saxena S, Dutta A. Geminin-Cdt1 balance is critical for genetic stability. Mutat Res. 2005 Jan 6;569(1-2):111-21.
162. Tachibana KE, Gonzalez MA, Guarguaglini G, Nigg EA, Laskey RA. Depletion of licensing inhibitor geminin causes centrosome overduplication and mitotic defects. EMBO Rep. 2005 Nov;6(11):1052-7.
163. Lin JJ, Dutta A. ATR pathway is the primary pathway for activating G2/M checkpoint induction after re-replication. J Biol Chem. 2007 Oct 19;282(42):30357-62.
164. Sugimoto N, Yoshida K, Tatsumi Y, Yugawa T, Narisawa-Saito M, Waga S, Kiyono T, Fujita M. Redundant and differential regulation of multiple licensing factors ensures prevention of re-replication in normal human cells. J Cell Sci. 2009 Apr 15;122(Pt 8):1184-91.
165. Karakaidos P, Taraviras S, Vassiliou LV, Zacharatos P, Kastrinakis NG, Kougiou D, Kouloukoussa M, Nishitani H, Papavassiliou AG, Lygerou Z, Gorgoulis VG. Over-expression of the replication licensing regulators hCdt1 and hCdc6 characterizes a subset of non-small-cell lung carcinomas: synergistic effect with mutant p53 on tumor growth and chromosomal instability--evidence of E2F-1 transcriptional control over hCdt1. Am J Pathol. 2004 Oct;165(4):1351-65.
166. Wohlschlegel JA, Kutok JL, Weng AP, Dutta A. Expression of geminin as a marker of cell proliferation in normal tissues and malignancies. Am J Pathol. 2002 Jul;161(1):267-73.
167. Bravou V, Nishitani H, Song SY, Taraviras S, Varakis J. Expression of the licensing factors, Cdt1 and Geminin, in human colon cancer. Int J Oncol. 2005 Dec;27(6):1511-8.
168. Obermann EC, Eward KL, Dogan A, Paul EA, Loddo M, Munson P, Williams GH, Stoeber K. DNA replication licensing in peripheral B-cell lymphoma. J Pathol. 2005 Feb;205(3):318-28.
169. Wharton SB, Hibberd S, Eward KL, Crimmins D, Jellinek DA, Levy D, Stoeber K, Williams GH. DNA replication licensing and cell cycle kinetics of oligodendroglial tumours. Br J Cancer. 2004 Jul 19;91(2):262-9.
170. Shrestha P, Saito T, Hama S, Arifn MT, Kajiwara Y, Yama-saki F, Hidaka T, Sugiyama K, Kurisu K. Geminin: a good prognostic factor in high-grade astrocytic brain tumors. Cancer. 2007 Mar 1;109(5):949-56.
171. Speleman F, Cauwelier B, Dastugue N, Cools J, Verhasselt B, Poppe B, Van Roy N, Vandesompele J, Graux C, Uyt-tebroeck A, Boogaerts M, De Moerloose B, Benoit Y, Sell-eslag D, Billiet J, Robert A, Huguet F, Vandenberghe P, De Paepe A, Marynen P, Hagemeijer A. A new recurrent inversion, inv(7)(p15q34), leads to transcriptional activation of HOXA10 and HOXA11 in a subset of T-cell acute lympho-blastic leukemias. Leukemia. 2005 Mar;19(3):358-66.
172. Argiropoulos B, Humphries RK. Hox genes in he-matopoiesis and leukemogenesis. Oncogene. 2007 Oct 15;26(47):6766-76.
173. Yellajoshyula D, Patterson ES, Elitt MS, Kroll KL. Gem-inin promotes neural fate acquisition of embryonic stem cells by maintaining chromatin in an accessible and hy-peracetylated state. Proc Natl Acad Sci U S A. 2011 Feb 22;108(8):3294-9.
174. Maes J, Maleszewska M, Guillemin C, Pfumio F, Six E, Andre-Schmutz I, Cavazzana-Calvo M, Charron D, Fran-castel C, Goodhardt M. Lymphoid-affliated genes are associated with active histone modifcations in human he-matopoietic stem cells. Blood. 2008 Oct 1;112(7):2722-9.
175. Weishaupt H, Sigvardsson M, Attema JL. Epigenetic chro-matin states uniquely defne the developmental plasticity of murine hematopoietic stem cells. Blood. 2010 Jan 14;115(2):247-56.
176. Cuddapah S, Barski A, Zhao K. Epigenomics of T cell activation, differentiation, and memory. Curr Opin Immunol. 2010 Jun;22(3):341-7.
177. Youngblood B, Davis CW, Ahmed R. Making memories that last a lifetime: heritable functions of self-renewing memory CD8 T cells. Int Immunol. 2010 Oct;22(10):797-803.
178. Agarwal S, Rao A. Modulation of chromatin structure regulates cytokine gene expression during T cell differentiation. Immunity. 1998 Dec;9(6):765-75.
179. Wei G, Wei L, Zhu J, Zang C, Hu-Li J, Yao Z, Cui K, Kan-no Y, Roh TY, Watford WT, Schones DE, Peng W, Sun HW, Paul WE, O'Shea JJ, Zhao K. Global mapping of H3K4me3 and H3K27me3 reveals specifcity and plasticity in lineage fate determination of differentiating CD4+ T cells. Immunity. 2009 Jan 16;30(1):155-67.
180. Chang S, Aune TM. Dynamic changes in histone-methyla-tion 'marks' across the locus encoding interferon-gamma during the differentiation of T helper type 2 cells. Nat Immunol. 2007 Jul;8(7):723-31.
181. Zhang F, Boothby M. T helper type 1-specifc Brg1 recruitment and remodeling of nucleosomes positioned at the IFN-gamma promoter are Stat4 dependent. J Exp Med. 2006 Jun 12;203(6):1493-505.
182. Dispirito JR, Shen H. Histone acetylation at the single-cell level: a marker of memory CD8+ T cell differentiation and functionality. J Immunol. 2010 May 1;184(9):4631-6.
183. Buckner JH. Mechanisms of impaired regulation by CD4(+) CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases. Nat Rev Immunol. 2010 Dec;10(12):849-59.